Source: Rheumatology international. Unidade: FM
Subjects: ESTUDOS RETROSPECTIVOS, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Isabela Bruna Pires et al. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatology international, v. 38, n. 2, p. 293-301, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00296-017-3821-3. Acesso em: 14 nov. 2024.APA
Borges, I. B. P., Silva, M. G., Misse, R. G., & Shinjo, S. K. (2018). Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatology international, 38( 2), 293-301. doi:10.1007/s00296-017-3821-3NLM
Borges IBP, Silva MG, Misse RG, Shinjo SK. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review [Internet]. Rheumatology international. 2018 ; 38( 2): 293-301.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s00296-017-3821-3Vancouver
Borges IBP, Silva MG, Misse RG, Shinjo SK. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review [Internet]. Rheumatology international. 2018 ; 38( 2): 293-301.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s00296-017-3821-3
